Teblik Drugs Private Limited, a active private limited company, was established on 02 February 1989 in Indore, Madhya Pradesh, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24232MP1989PTC005061. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹3.50 M and a paid-up capital of ₹2.51 M.
Formerly known as Teblik Drugs Limited. It upholds a compliant status. Employing 16 professional, Its leadership includes Soham Prakash Sharma (Director), Renu Sharma (Director), Shobhit Sharma (Director). Past directors included Anil Bhatia, Satyanarayan Rathore. It holds ₹1.25 Cr open charges and ₹3.62 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 17/1, North Rajmohalla, Indore, Madhya Pradesh, 452002.
U24232MP1989PTC005061
005061
02 February 1989
₹3.50 M
₹2.51 M
Roc Gwalior
Unlisted
Active
Explore comprehensive insights into Teblik Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Soham Prakash Sharma | Director | 02 Feb 1989 | Current |
| Renu Sharma | Director | 28 Mar 2014 | Current |
| Shobhit Sharma | Director | 28 Mar 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Apr 2014 | Past |
| Pramod Abcsdd | Director | 11 Nov 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Teblik Drugs Private Limited, for the financial year ended 2017, experienced modest growth in revenue, with a 0.15% increase. The company also saw a substantial improvement in profitability, with a 15.13% increase in profit. The company's net worth moved up by a moderate rise of 3.53%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Teblik Drugs had a promoter holding of 19.99% and a public holding of 80.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹12,500,000.00
₹36,175,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Oct 2025 | Others | ₹7.50 M | Open |
| 31 May 2022 | Others | ₹5.00 M | Open |
| 23 Jun 2016 | Others | ₹3.60 M | Satisfied |
| 29 Jun 2009 | Small Industries Development Bank Of India | ₹2.50 M | Satisfied |
| 13 Jun 2007 | Bank Of Baroda | ₹2.01 Cr | Satisfied |
Explore comprehensive loan charge details -
Teblik Drugs has a workforce of 16 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Teblik Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Teblik Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Others amounted to Rs. 7.50 M with Charge ID 101181977 was registered on 24 Oct 2025. was completed.
Progress on Teblik Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Teblik Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Gwalior. was documented.
The activity A charge with Others amounted to Rs. 5.00 M with Charge ID 100579023 was registered on 31 May 2022. was completed.
The activity A charge registered on 23 Jun 2016 via Charge ID 100042702 with Others was fully satisfied on 18 May 2022. was completed.
The activity A charge with Others of Rs. 3.60 M registered on 23 Jun 2016 with Charge ID 100042702 was modified on 09 Feb 2022. was completed.
The CIN of Teblik Drugs Private Limited is U24232MP1989PTC005061.
Teblik Drugs Private Limited is headquartered at 17/1, North Rajmohalla, Indore, Madhya Pradesh, 452002.
Teblik Drugs Private Limited was incorporated on 02 February 1989.
The current directors of Teblik Drugs Private Limited are
The primary industry of Teblik Drugs Private Limited is Trade.
Teblik Drugs Private Limited is unlisted.
The authorized capital of Teblik Drugs Private Limited is ₹3.50 M, and the paid-up capital is ₹2.51 M.
The compliance status of Teblik Drugs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX